Organogenesis Holdings Inc. operates as a leading regenerative medicine pioneer dedicated to the development, manufacture, and commercialization of innovative medical solutions that address unmet needs in tissue replacement and wound healing. The company leverages advanced bio-engineering and cellular technologies to manufacture products that stimulate the body's natural tissue repair mechanisms, helping patients recover from chronic, non-healing wounds and complex surgical complications while improving overall clinical outcomes.